Inpharma Weekly

, Volume 1017, Issue 1, pp 9–10 | Cite as

Tazarotene heads for success in psoriasis

  • Rodger Hall
Newsletter Article


The full results of a double-blind, phase III study of tazarotene involving patients with psoriasis were presented at this year’s Dermatology Update [ Montreal, Canada; October 1995 ]. The data showed that tazarotene gel significantly reduced lesion development, compared with placebo, and was well tolerated. These results bode well for the new retinoid, which was submitted to the US FDA in June 1995 for marketing approval as a treatment for acne and psoriasis.


Psoriasis Acne Retinoid Plaque Psoriasis Tazarotene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1995

Authors and Affiliations

  • Rodger Hall

There are no affiliations available

Personalised recommendations